NEUTROPENIA (LOW WHITE BLOOD CELL COUNT)

Clinical trials for NEUTROPENIA (LOW WHITE BLOOD CELL COUNT) explained in plain language.

Never miss a new study

Get alerted when new NEUTROPENIA (LOW WHITE BLOOD CELL COUNT) trials appear

Sign up with your email to follow new studies for NEUTROPENIA (LOW WHITE BLOOD CELL COUNT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New approach aims to keep breast cancer treatment on track by protecting blood cells

Disease control Not yet recruiting

This study is testing whether a drug called leucogen can prevent a serious side effect of breast cancer treatment. Researchers want to see if leucogen reduces severe drops in white blood cells (neutropenia) in early-stage breast cancer patients taking ribociclib with hormone ther…

Matched conditions: NEUTROPENIA (LOW WHITE BLOOD CELL COUNT)

Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

NEUTROPENIA (LOW WHITE BLOOD CELL COUNT)

Get alerted when new NEUTROPENIA (LOW WHITE BLOOD CELL COUNT) trials appear

New approach aims to keep breast cancer treatment on track by protecting blood cells